Knockdown of Inhibitor of Growth Protein 2 Inhibits Cell Invasion and Enhances Chemosensitivity to 5-FU in Human Gastric Cancer Cells

By Zhong Juan   Yang Lei   Liu Ning   Zheng Jun   Lin Cong-Yao  

Digestive Diseases and Sciences, Vol. 58, Iss. 11, 2013-11 ,pp. : 3189-3197

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions

By Andersson Roland   Aho Ursula   Nilsson Bo   Peters Godefridus   Pastor-Anglada Marcal   Rasch Wenche   Sandvold Marit  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 782-786

Informa Healthcare

Access to resources Recommend Favorite

Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Cancer

By Crane C.H.   Janjan N.A.   Evans D.B.   Wolff R.A.   Ballo M.T.   Milas L.   Mason K.   Charnsangavej C.   Pisters P.W.T.   Lee J.E.   Lenzi R.   Vauthey J.N.   Wong A.   Phan T.   Nguyen Q.   Abbruzzese J.L.  

International Journal of Pancreatology, Vol. 29, Iss. 1, 2001-03 ,pp. : 9-18

Humana Press, Inc

Access to resources Recommend Favorite

Effect of Low-Dose Gemcitabine on Unresectable Pancreatic Cancer in Elderly Patients

By  

Digestion, Vol. 84, Iss. 3, 2011-08 ,pp. : 230-235

Karger

Access to resources Recommend Favorite

Differential Expression of Gastrin, Cholecystokinin-A and Cholecystokinin-B Receptor mRNA in Human Pancreatic Cancer Cell Lines

By Monstein H.-J.   Ohlsson B.   Axelson J.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 7, 2001-07 ,pp. : 738-743

Informa Healthcare

Access to resources Recommend Favorite